5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.04▲ | 9.07▼ | 9.11▼ | 8.98▲ | 7.50▲ |
MA10 | 9.02▲ | 9.10▼ | 9.11▼ | 7.93▲ | 6.88▲ |
MA20 | 9.05▲ | 9.09▼ | 9.01▲ | 7.21▲ | 6.06▲ |
MA50 | 9.09▼ | 8.95▲ | 8.07▲ | 6.63▲ | 4.71▲ |
MA100 | 9.11▼ | 7.99▲ | 7.37▲ | 5.87▲ | 3.90▲ |
MA200 | 9.02▲ | 7.30▲ | 6.79▲ | 4.81▲ | 2.88▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | -0.032▼ | -0.065▼ | 0.257▲ | 0.264▲ |
RSI | 51.713▲ | 54.152▲ | 67.018▲ | 84.818▲ | 84.099▲ |
STOCH | 56.200 | 29.923 | 45.024 | 92.368▲ | 83.731▲ |
WILL %R | -41.176 | -59.184 | -64.557 | -9.331▲ | -6.148▲ |
CCI | 57.116 | -149.535▼ | -39.293 | 103.278▲ | 247.965▲ |
Wednesday, May 15, 2024 06:00 AM
Continued progress enrolling in its VMT-α-NET and VMT01 clinical trialsDisclosed a new internally discovered molecule that targets fibroblast ...
|
Tuesday, May 14, 2024 05:00 PM
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...
|
Tuesday, May 14, 2024 11:00 AM
Raymond James raised the price target for the Adma Biologics Inc (NASDAQ:ADMA) stock to “a Strong buy”. The rating was released on July 19, 2023, according to finviz. The research report from Raymond ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 9.135 | 9.135 | 8.965 | 9.065 | 325,361 |
15/05/24 | 9.27 | 9.33 | 9.05 | 9.10 | 3,129,945 |
14/05/24 | 8.75 | 9.17 | 8.75 | 9.16 | 3,768,573 |
13/05/24 | 8.78 | 8.90 | 8.425 | 8.77 | 5,044,771 |
10/05/24 | 8.20 | 9.02 | 7.96 | 8.81 | 11,699,945 |
09/05/24 | 6.93 | 6.97 | 6.84 | 6.93 | 3,017,712 |
08/05/24 | 6.90 | 6.91 | 6.72 | 6.86 | 2,399,795 |
07/05/24 | 6.93 | 6.97 | 6.86 | 6.91 | 1,968,816 |
06/05/24 | 6.90 | 6.94 | 6.76 | 6.91 | 2,412,729 |
03/05/24 | 6.78 | 6.81 | 6.65 | 6.81 | 2,985,668 |
|
|
||||
|
|
||||
|
|